Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 277INDUSTRY 135NETWORK 14NIH 8OTHER_GOV 6UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 24Stomach Neoplasms 21Rectal Neoplasms 15Colorectal Neoplasms 12Esophageal Squamous Cell Carcinoma 6Carcinoma, Hepatocellular 5Colonic Neoplasms 3Radiation Injuries 2Urinary Bladder Neoplasms 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Locally Advanced Pancreatic Cancer 1Liver Neoplasms 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1HER2-positive 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Extrapancreatic Neuroendocrine Tumor 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Anus Neoplasms 1Advanced Pancreatic Cancer 1Advanced Colorectal Cancer 1Adenocarcinoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Biliary Tract Neoplasms × Gastrointestinal × Clear all
NCT03830606 2021-02-01

The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma

ChineseAMS

Phase 2 Completed
54 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡